Clinical TrialsSearch results
Number of results: 483
Recruiting
- Research on remote exercise support for esophageal cancer patients
- Esophageal cancer
- Noma Tomohiro
- 2022-08-20
Recruiting
- An investigational study of chemoradiosensitivity prediction with genetic profiling of esophageal biopsy for squamous cell carcinoma of the esophagus
- Esophageal cancer
- University of Toyama
- 2007-02-01
Other
- The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS)
- Essential hypertension
- JATOS Study Group
- 2008-02-15
Other
- Olmesartan-based versus Amlodipine-based Strategies for Circulating Marker Modification in Essential Hypertension Study
- Essential Hypertension
- Department of Cardiovascular Medicine, Kyoto University Hospital
- 2006-11-21
Other
- Japan Home versus Office Measurement Evaluation for Heart Rate study
- Essential Hypertension
- Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Pharmaceutical Sciences and Medicine
- 2008-08-01
Other
- Gene evaluation for antihypertensive drug effects study
- essential hypertension
- National Cardiovascular Center
- 2005-09-07
Other
- Randomized phase 3 trial of prophylactic cranial irradiation for patients with extensive small-cell lung cancer
- Extensive small-cell lung cancer patients with no brain metastasis who had a response to platinum-based first-line chemotherapy,
- Yamamoto Group, Grant for Cancer Research, Ministry of Health, Labour, and Welfare
- 2009-03-05
Other
- A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)
- extensive-disease small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2007-05-22
Other
- Randomized phase II trial comparing amrubicine/irinotecan with cisplatin/irinotecan in patients with extensive-stage small-cell lung cancer: (JMTO LC 08-01)
- extensive-disease small-cell lung cancer
- The Japan-multinational Trial Organization
- 2008-07-15
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14